Skip to main contentSkip to navigation
Sirius Investors
Bayer AG

Bayer AG

BAYRY
OTCHealthcare

Bayer AG (BAYRY) Investment Research Dashboard

About Bayer AG (BAYRY) stock analysis

Get live BAYRY stock price $13.49, comprehensive Bayer AG stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time BAYRY stock data and investment insights.

13.49
0.75%Today
Market Cap
53.01B
Volume
101.74K
52W High
15.23
52W Low
7.19

Loading chart data...

Bayer AG (BAYRY) Overview

Bayer AG (BAYRY) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - General industry . As of the latest trading session, BAYRY trades at $13.49 with a market capitalization of 53.01B . Over the past 52 weeks, BAYRY has traded between $7.19 and $15.23 , with the current price positioned at approximately 78% of this range . The stock currently tra...

Key Takeaways

  • Operates in the Healthcare sector (Drug Manufacturers - General)
  • Market cap: 53.01B
  • Current price: $13.49
  • 52-week range: $7.19 - $15.23
  • P/E ratio: 9.05

Investment Score

TTM (current)
Unavailable

A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Bayer Aktiengesellschaft, commonly known as Bayer AG, functions as a prominent global life sciences company through its various subsidiaries. Its extensive operations are strategically segmented into Pharmaceuticals, Consumer Health, and Crop Science...

Company Information

CEO
William N. Anderson
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
90587

Contact Information

Address
Kaiser-Wilhelm-Allee 1
Country
DE

Investment Analysis & Business Insights

Healthcare
Drug Manufacturers - General

Investment Highlights

Strong presence in the Healthcare sector with established market position

Valuation metrics suggest potential value opportunity (P/E: 9.1)

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Bayer AG shareholders
  • Market volatility can significantly impact stock price, especially for mid-cap stocks
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Bayer AG
  • Investors should consider how Bayer AG fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

53.01B

P/E Ratio (TTM)

9.05

Beta

0.83

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.

Healthcare (1D)

78/100 ⭐⭐⭐⭐⭐

Overall
+0.7%
NYSE
+0.6%
NASDAQ
+0.7%
Sector1D1W1MP/EScore
Financial Services+2.2%+3.1%+4.3%19.3
98/100⭐⭐⭐⭐⭐
Healthcare+0.7%+1.3%+1.6%24.1
78/100⭐⭐⭐⭐⭐
Communication Services+1.4%-0.7%+2.9%22.2
74/100⭐⭐⭐⭐⭐
Consumer Defensive-0.2%+1.8%+0.7%29.7
64/100⭐⭐⭐⭐
Basic Materials+0.4%+1.2%-0.2%25.2
61/100⭐⭐⭐⭐
Real Estate-0.5%+0.0%-2.5%29.2
43/100⭐⭐⭐
Energy-2.1%-3.7%-4.1%19.1
39/100⭐⭐
Utilities-1.0%+0.0%-4.4%26.8
37/100⭐⭐
Industrials+0.6%+0.4%-9.9%30.1
23/100
Consumer Cyclical+0.5%-1.5%-5.8%43.0
18/100
Technology+0.6%-1.6%-7.2%40.7
15/100

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-29.